Nardev S. Khurmi

4.4k total citations · 3 hit papers
49 papers, 3.0k citations indexed

About

Nardev S. Khurmi is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Analytical Chemistry. According to data from OpenAlex, Nardev S. Khurmi has authored 49 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 11 papers in Surgery and 9 papers in Analytical Chemistry. Recurrent topics in Nardev S. Khurmi's work include Cardiac electrophysiology and arrhythmias (21 papers), Cardiac pacing and defibrillation studies (18 papers) and Analytical Methods in Pharmaceuticals (9 papers). Nardev S. Khurmi is often cited by papers focused on Cardiac electrophysiology and arrhythmias (21 papers), Cardiac pacing and defibrillation studies (18 papers) and Analytical Methods in Pharmaceuticals (9 papers). Nardev S. Khurmi collaborates with scholars based in United Kingdom, United States and Italy. Nardev S. Khurmi's co-authors include Renato D. Lópes, Hertzel C. Gerstein, Kelley R. Branch, Stefano Del Prato, Carolyn S.P. Lam, Richard E. Pratley, Naveed Sattar, Julio Rosenstock, Michael J. Bowles and Edward B. Raftery and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Nardev S. Khurmi

48 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

2021 921 citations Naveed Sattar, Kelley R. Branch et al. profile →
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes

2021 503 citations Hertzel C. Gerstein, Naveed Sattar et al. profile →
Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

2010 436 citations Christopher P. Cannon, Robert A. Harrington et al. The Lancet profile →

Peers

Countries citing papers authored by Nardev S. Khurmi

Since Specialization

Citations

This map shows the geographic impact of Nardev S. Khurmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nardev S. Khurmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nardev S. Khurmi more than expected).

Fields of papers citing papers by Nardev S. Khurmi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nardev S. Khurmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nardev S. Khurmi. The network helps show where Nardev S. Khurmi may publish in the future.

Co-authorship network of co-authors of Nardev S. Khurmi

This figure shows the co-authorship network connecting the top 25 collaborators of Nardev S. Khurmi. A scholar is included among the top collaborators of Nardev S. Khurmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nardev S. Khurmi. Nardev S. Khurmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efpeglenatide and Clinical Outcomes With and Without Concomitant Sodium-Glucose Cotransporter-2 Inhibition Use in Type 2 Diabetes: Exploratory Analysis of the AMPLITUDE-O Trial 2021 ·Circulation ·Carolyn S.P. Lam, Chinthanie Ramasundarahettige, Kelley R. Branch, Naveed Sattar, Julio Rosenstock, Richard E. Pratley, Stefano Del Prato, Renato D. Lópes, Elisabeth Niemoeller, Nardev S. Khurmi, Seung Jae Baek, Hertzel C. Gerstein	82
2	Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial 2014 ·Journal of the American College of Cardiology ·Kenneth W. Mahaffey, Claes Held, Daniel Wojdyla, Stefan James, Hugo A. Katus, Steen Husted, Philippe Gabríel Steg, Christopher P. Cannon, Richard C. Becker, Robert F. Storey, Nardev S. Khurmi, José Carlos Nicolau, Cheuk‐Man Yu, Diego Ardissino, Andrzej Budaj, João Morais, (unknown), Anders Himmelmänn, Robert A. Harrington, Lars Wallentin	37
3	Pulmonary Function in Patients With Acute Coronary Syndrome Treated With Ticagrelor or Clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] Pulmonary Function Substudy) 2011 ·The American Journal of Cardiology ·Robert F. Storey, Richard C. Becker, Robert A. Harrington, Steen Husted, Stefan James, Frank Cools, Philippe Gabríel Steg, Nardev S. Khurmi, Håkan Emanuelsson, Soo Teik Lim, Christopher P. Cannon, Hugo A. Katus, Lars Wallentin	54
4	Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes 2011 ·European Heart Journal ·Robert F. Storey, Richard C. Becker, Robert A. Harrington, Steen Husted, Stefan James, Frank Cools, Philippe Gabríel Steg, Nardev S. Khurmi, Håkan Emanuelsson, (unknown), Richard Cairns, Christopher P. Cannon, Lars Wallentin	133
5	Efficacy and Safety of Rosuvastatin 5 mg in Combination with Fenofibric Acid 135 mg in Patients with Mixed Dyslipidemia – A Phase 3 Study 2010 ·Cardiovascular Drugs and Therapy ·Eli M. Roth, Robert S. Rosenson, Dawn M. Carlson, (unknown), Carolyn M. Setze, James W. Blasetto, Nardev S. Khurmi, James C. Stolzenbach, Laura Williams	20
6	Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study breakdown → 2010 ·The Lancet ·Christopher P. Cannon, Robert A. Harrington, Stefan James, Diego Ardissino, Richard C. Becker, Håkan Emanuelsson, Steen Husted, Hugo A. Katus, Mátyás Keltai, Nardev S. Khurmi, Frederic Kontny, Basil S. Lewis, Philippe Gabríel Steg, Robert F. Storey, Daniel Wojdyla, Lars Wallentin	436
7	Baseline Characteristics of Participants in the JUPITER Trial, A Randomized Placebo-Controlled Primary Prevention Trial of Statin Therapy Among Individuals With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein 2007 ·The American Journal of Cardiology ·Paul M. Ridker, Francisco Antônio Helfenstein Fonseca, Jacques Genest, Antonio M. Gotto, John J.P. Kastelein, Nardev S. Khurmi, Wolfgang Köenig, Peter Libby, Alberto Lorenzatti, Børge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn	96
8	723-4 Cardiovascular and Neurohormonal Effects of SDZ WAG 994, a Selective Adenosine A 1 Receptor Agonist, in Man 1995 ·Journal of the American College of Cardiology ·Inder S. Anand, Y. Chandrashekhar, (unknown), Susan Ziesche, (unknown), Dianne Judd, Nardev S. Khurmi, Jay N. Cohn	1
9	The effect of Benazepril on ischemia during daily activity in chronic stable angina 1991 ·Journal of the American College of Cardiology ·Dan Tzivoni, Shmuel Gottlieb, Aharon Medina, Alex Gavish, Nardev S. Khurmi, Shlomo Stern	2
10	Effects of benazepril and metoprolol OROS alone and in combination on myocardial ischemia in patients with chronic stable angina 1990 ·Journal of the American College of Cardiology ·Werner Klein, Nardev S. Khurmi, (unknown), (unknown)	27
11	Lack of diurnal variation in maximal symptom-limited exercise test response in chronic stable angina 1988 ·The American Journal of Cardiology ·Nardev S. Khurmi, Edward B. Raftery	12
12	Diltiazem and Propranolol Combination for the Treatment of Chronic Stable Angina Pectoris 1987 ·Clinical Cardiology ·(unknown), Nardev S. Khurmi, Michael J. Bowles, E. B. Raftery	14
13	Effect of propranolol on indices of intermittent myocardial ischemia, assessed by exercise testing and ambulatory st‐segment monitoring 1986 ·Clinical Cardiology ·Nardev S. Khurmi, Michael J. Bowles, (unknown), E. B. Raftery	21
14	Randomized Double-blind Placebo-controlled Comparison of Nicardipine and Nifedipine in Patients with Chronic Stable Angina Pectoris 1986 ·CHEST Journal ·Michael J. Bowles, Nardev S. Khurmi, (unknown), (unknown)	13
15	Are anti‐platelet drugs of value in the management of patients with chronic stable angina? A study with ticlopidine 1986 ·Clinical Cardiology ·Nardev S. Khurmi, Michael J. Bowles, E. B. Raftery	6
16	Nicardipine in chronic stable angina: Objective assessment with computer-assisted exercise testing and ambulatory ST segment monitoring. 1985 ·British Journal of Clinical Pharmacology ·Michael J. Bowles, Nardev S. Khurmi, (unknown), E. B. Raftery	5
17	Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina 1984 ·Journal of the American College of Cardiology ·Nardev S. Khurmi, Michael J. Bowles, V. Bala Subramanian, Edward B. Raftery	54
18	Randomized double-blind comparison of gallopamil and propranolol in stable angina pectoris 1984 ·The American Journal of Cardiology ·Nardev S. Khurmi, (unknown), Michael J. Bowles, V. Bala Subramanian, Edward B. Raftery	38
19	Calcium antagonist withdrawal syndrome: objective demonstration with frequency-modulated ambulatory ST-segment monitoring. 1983 ·BMJ ·V. Bala Subramanian, Michael J. Bowles, Nardev S. Khurmi, Anthony B. Davies, (unknown), E. B. Raftery	42
20	Objective evaluation of three dose levels of diltiazem in patients with chronic stable angina 1983 ·Journal of the American College of Cardiology ·V. Bala Subramanian, Nardev S. Khurmi, Michael J. Bowles, (unknown), Edward B. Raftery	59

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact